Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
It can promote tissue repair, reduces inflammation, enhances angiogenesis (new blood vessel formation), and remains stable in gastric juice enabling effective oral administration
Because these medications address the biological drivers of metabolic dysfunction, they offer a powerful medical foundation for those ready to transform their health journey
In June 2025, Eli Lilly reported Phase III ACHIEVE-1 Survodutide (BI 456906): Boehringer Ingelhium Survodutide (BI 456906) is a GCGR/GLP1 dual agonist being developed by Boehringer Ingelhium
The price is $64 for 30 servings with 2 capsules per serving
Regeneron / Hansoh (HS-20094) The Regeneron licensing (2.0B) is another analog: smaller upfront outlay, big milestone payoff
US$ 27.21
US$ 24.74
US$ 22.97
US$ 26.85
US$ 23.57
US$ 23.85
US$ 20.84
US$ 20.31
